This inventor holds 2 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent. Top assignee: Fujifilm Corporation. Active years: 2019-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2020
Title: Yusuke Nagato: Innovator in Pharmaceutical Chemistry
Introduction
Yusuke Nagato is a prominent inventor based in Toyama, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of nitrogen-containing heterocyclic compounds. With a total of 2 patents to his name, Nagato's work is recognized for its potential impact on pharmaceutical products.
Latest Patents
Nagato's latest patents focus on methods for manufacturing nitrogen-containing heterocyclic compounds. One of his notable inventions is a method that provides an industrial approach to producing a compound with excellent FLT3 inhibitory activity. This compound is useful as a pharmaceutical active ingredient, showcasing Nagato's commitment to advancing medical science. The manufacturing method involves a compound represented by General Formula [14], where R represents a Calkyl group that may be substituted, and R represents a leaving group or similar.
Career Highlights
Yusuke Nagato is currently employed at Fujifilm Corporation, where he continues to innovate in the field of pharmaceutical chemistry. His work at Fujifilm has allowed him to collaborate with other talented professionals and contribute to the company's research and development efforts.
Collaborations
Nagato has worked alongside notable colleagues such as Tatsuya Murakami and Tomoyuki Tanaka. These collaborations have further enriched his research and have led to advancements in their shared field of expertise.
Conclusion
Yusuke Nagato is a dedicated inventor whose work in pharmaceutical chemistry is paving the way for new medical advancements. His innovative methods for manufacturing nitrogen-containing heterocyclic compounds highlight his significant contributions to the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
